Finnish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Furocyst - Poly Cystic Ovary Syndrome Study

Vain rekisteröityneet käyttäjät voivat kääntää artikkeleita
Kirjaudu sisään Rekisteröidy
Linkki tallennetaan leikepöydälle
TilaValmistunut
Sponsorit
Chemical Resources

Avainsanat

Abstrakti

Poly cystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, affecting approximately 5%-10% of all females worldwide . PCOS is a hormonal disorder that involves multiple organ systems within the body. Its cardinal features are Hyperandrogenism and polycystic ovary (PCO) morphology. Women with PCOS may complains about irregular menstrual periods or heavy menstrual bleeding, infertility, excessive growth of coarse facial and body hair, obesity, oiliness of the skin, seborrhea, and cystic acne.

Kuvaus

The symptoms of PCOS are anovulation, resulting in irregular menstruation (amenorrhea and oligomenorrhea) ovulation-related infertility, and polycystic ovaries, often associated with obesity, Type 2 diabetes, and high cholesterol levels. The level of serum insulin and insulin resistance are higher in women with PCOS (Hyperinsulinemia).Insulin resistance, defined as the decreased insulin mediated glucose utilization it is more common in women with PCOS up to 50 % in both obese and non obese women . It has also been recognized that some women with this syndrome will have PCO without clinical evidence of androgen excess, but will display evidence of ovarian dysfunction .

It is believed to be that, the Hyperinsulinemia of PCOS stimulates the androgens production and increase the activity by decreasing the sex hormone binding globulin (SHBG) thus increasing the free active testosterone level and by the activating the cytochrome P 450 C 17 alpha enzymatic system that controls androgens production.

The diagnosis of PCOS is based on Hyperandrogenism and chronic anovulation in the absence of specific pituitary or adrenal disease , and have disrupted ovulatory function with chronic oligomenorrhea (cycle length > 35 day) or amenorrhea (cycle length > 12 week) and typical appearance of polycystic ovaries by ultrasound according to the criteria of the Rotterdam consensus meeting 2003 for diagnosis of PCOS. The different diagnostic tests needed to adequately assess for the possibility of PCOS e.g. Pregnancy test, TSH level (for Hyperthyroidism), Prolactin test (for Hyperprolactinemia), Total testosterone (for ovarian tumor) and some tests forevaluating the insulin resistance syndrome in women: Waist circumference (>88 cm), Triglycerides (>150 mg/dL), HDL Cholesterol (<50 mg/dL), Blood pressure (>130/85) and Fasting glucose (>110 mg/dL). Fasting glucose- to- insulin ratio and 2 hour oral glucose tolerance test (2h- OGTT 140 - 199 mg/dL) may be better predictor of insulin resistance .

The management of the PCOS is symptoms specific e.g.

1. Oral contraceptives, periodic progesterone withdrawal for the control of irregular menstruation.

2. Oral contraceptives, Metformin and anti-androgens (Spironolactone) for the

Hirsutism.

3. Clomiphene citrate, Metformin and thiazolidinediones for infertility. A recent study shown that, the combination of Metformin plus Clomiphene citrate should be considered as the First line treatment for infertile women with PCOS .

4. Metformin and lifestyle modification for the insulin resistance and diabetes mellitus.

All these management options are only for "acute" not for "chronic". The long-term management approach for the PCOS is needed which will be based on management of most affecting factor insulin resistance.

Päivämäärät

Viimeksi vahvistettu: 07/31/2016
Ensimmäinen lähetys: 09/28/2015
Arvioitu ilmoittautuminen lähetetty: 03/02/2016
Ensimmäinen lähetetty: 03/08/2016
Viimeisin päivitys lähetetty: 09/13/2017
Viimeisin päivitys lähetetty: 09/14/2017
Todellinen opintojen alkamispäivä: 03/25/2015
Arvioitu ensisijainen valmistumispäivä: 06/30/2017
Arvioitu tutkimuksen valmistumispäivä: 06/30/2017

Ehto tai tauti

PCOS

Interventio / hoito

Dietary Supplement: Furocyst

Vaihe

-

Varren ryhmät

VarsiInterventio / hoito
Experimental: Furocyst
Furocyst 500mg capsule, BD
Dietary Supplement: Furocyst
Furocyst caps BD

Kelpoisuusehdot

Tutkimukseen soveltuvat iät 18 Years Vastaanottaja 18 Years
Sukupuolet, jotka ovat kelpoisia tutkimukseenFemale
Hyväksyy terveelliset vapaaehtoisetJoo
Kriteeri

Inclusion Criteria:

- Premenopausal women between 18-45 years of age and BMI less than 42

- Diagnosed with PCOS by Rottadom Criteria

- Adequate hepatic, renal, Cardiac and hematological functions.

- Patients willing to Participate and give informed consent in writing as well as in audio-visual form for the study.

- Stable weight for last two months (Change of weight<3kg)

Exclusion Criteria:

- Male

- Post menopausal women

- Women with hysterectomy

- Hyperprolactinemia

- Patients with congenital adrenal hyperplasia

- Patients suffering from Cushing's syndrome

- Acute or chronic Medical illness including Hepatic, Cardiac or renal insufficiency, COPD,Gastrointestinal Disorders

- Uncontrolled Hypertensive or known Diabetics on drugs

- Use of oral contraceptives or HRT for last three months

- Smoking or drug addicts or with psychiatric illness

- Patients diagnosed with androgen secreting tumors.

- Patients with thyroid dysfunction (T3, T4 level is higher than that in normal women of reproductive age)

- Patients with Hypo-gonadotropic and Hypo-gonadism (central origin of ovarian dysfunction)

- Pregnant or lactating mothers

Tulokset

Ensisijaiset tulosmittaukset

1. Reduction in Overian volume & Number of overian Cysts [12 weeks]

Toissijaiset tulosmittaukset

1. Restoration of normal menstrual cycle [12 weeks]

Liity facebook-sivullemme

Täydellisin lääketieteellinen tietokanta tieteen tukemana

  • Toimii 55 kielellä
  • Yrttilääkkeet tieteen tukemana
  • Yrttien tunnistaminen kuvan perusteella
  • Interaktiivinen GPS-kartta - merkitse yrtit sijaintiin (tulossa pian)
  • Lue hakuusi liittyviä tieteellisiä julkaisuja
  • Hae lääkekasveja niiden vaikutusten perusteella
  • Järjestä kiinnostuksesi ja pysy ajan tasalla uutisista, kliinisistä tutkimuksista ja patenteista

Kirjoita oire tai sairaus ja lue yrtteistä, jotka saattavat auttaa, kirjoita yrtti ja näe taudit ja oireet, joita vastaan sitä käytetään.
* Kaikki tiedot perustuvat julkaistuun tieteelliseen tutkimukseen

Google Play badgeApp Store badge